RTI Biologics Announces Launch of New Meniscus Allograft Instrumentation
7/7/2011 9:55:31 AM
ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, announces the launch of new meniscus allograft instrumentation. The new instrumentation features enhancements to the design of several critical components of the set resulting from surgeon recommendations to enhance the implant procedure. The new meniscus allograft instrumentation kits began shipping together with RTI meniscus grafts on July 5, 2011. For more information or to speak with RTI’s customer service please contact 1-800-624-7238 or visit the RTI exhibit at the American Orthopaedic Society of Sports Medicine Annual Meeting, July 7-10 in San Diego, CA.